Skip to content

Phase 1 Safety and Effects of an Automated Cold Compression Pad and an Automated Hot or Cold Compression Device in Healthy Volunteers

Phase 1 Safety and Effects of an Automated Cold Compression Pad and an Automated Hot or Cold Compression Device in Healthy Volunteers

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20260731010
Enrollment
1
Registered
2026-07-31
Start date
2027-01-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain and swelling following arthroscopic shoulder tendon repair, particularly rotator cuff repair, are conditions that can impair mobility, rehabilitation, and patients&#039

Interventions

Participants will receive the automated cold compress innovation, including both the cold compress pad and the cooling device, and will undergo assessments of the effectiveness and safety of the innov
Device Feasibility
Healthy volunteers

Sponsors

Thammasat University Hospital
Lead Sponsor
Thammasat University
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing arthroscopic shoulder tendon repair at Thammasat University Hospital during both regular and after hours service periods 2. No history of cold sensitivity or allergic reactions to cold 3. No peripheral vascular diseases such as Buerger's disease 4. No diabetes mellitus with peripheral sensory neuropathy 5. No history of Raynaud's disease 6. No postoperative complications affecting consciousness or sensory function or requiring specific treatment such as shock or respiratory arrest 7. No history of morphine allergy or substance abuse 8. American Society of Anesthesiologists physical status class 1 to 3 9. Normal cognitive function vision hearing and communication ability 10. No psychiatric or neurological conditions affecting communication such as Alzheimer's disease or delirium 11. Patients receiving general anesthesia or regional anesthesia according to the treatment plan 12. Willingness to participate in the study and provide informed consent

Exclusion criteria

Exclusion criteria: 1. Patients who refuse to participate or withdraw their informed consent during the study 2. Patients with a history of cold sensitivity or allergic reactions to cold 3. Patients with peripheral vascular diseases such as Buerger's disease or Raynaud's disease 4. Patients with diabetes mellitus associated with peripheral sensory neuropathy 5. Patients with a history of morphine allergy or substance abuse 6. Patients who develop postoperative complications affecting consciousness or sensory function or requiring urgent medical treatment such as shock or respiratory arrest 7. Patients with communication difficulties, visual or hearing impairments, or psychiatric or neurological disorders that may affect study assessments 8. Patients who are unable to complete follow up during the 36 hour postoperative period

Design outcomes

Primary

MeasureTime frame
Safety of cold compress device use Throughout the 3-hour intervention period Assessment of adverse effects such as skin redness, numbness, abnormal pain, or cold injury, evaluated by clinical examination and symptom record form

Secondary

MeasureTime frame
Cold therapy related complications Within 3 hours after device initiation Occurrence of cold related complications such as skin injury, frostbite, or local tissue irritation recorded by the investigator

Countries

Thailand

Contacts

Public ContactNuttakarn Koontorn

Thammasat University Hospital, Thammasat University

nut.kitty2010@gmail.com0622642429

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026